Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;43(1):925-931.
doi: 10.1080/08897077.2021.2010257.

Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses

McKenna C Eastment  1 , Ayushi Gupta  1 , Jocelyn James  1 , Barbra A Richardson  2   3 , Leeya Pinder  4 , H Nina Kim  1   3 , Anna Wald  1 , Judith I Tsui  1
Affiliations

Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses

McKenna C Eastment et al. Subst Abus. 2022.

Abstract

Background: Substance use-related diagnoses are common and associated with poor health outcomes. The objective of this analysis was to compare rates of cervical cancer screening, screening abnormalities, and follow-up care in women with and without a substance use-related diagnosis seen for primary care between January 1, 2016 and December 31, 2019 in the University of Washington healthcare system. Methods: This study included women aged 21-65 years of age who had at least one outpatient visit between January 1, 2016 and December 31, 2019 within one of 45 primary care or women's health clinics in the academic healthcare system. Exposure status was defined using ICD10 codes for substance-use related diagnoses or no substance-use related diagnoses. Only first cervical cancer screening was included. Generalized linear models with a binomial family and log link were used to estimate risk ratios. Results: 3845 women had a substance use-related diagnosis and 89214 did not. Women with a substance use-related diagnosis were less likely to be screened for cervical cancer (44%, 1675/3845) compared to women without a substance use-related diagnosis (49%, 43338/89214; relative risk [RR] 0.90, 95% CI 0.86-0.93). Women with a substance use-related diagnosis were also more likely to have an abnormal screening result (18%, 304/1675) compared to women without a substance use-related diagnosis (10%, 4528/43338; RR 1.74, 95% CI 1.56-1.93). Follow-up for abnormal screens did not differ significantly between groups (24 vs 25%; RR 0.80, 95% CI 0.55-1.17). Conclusion: To combat disparities in cervical cancer screening for women with substance use-related diagnoses, public health efforts should expand access to screening where women with substance use-related diagnoses are seen, including acute care, inpatient hospitalizations, and addiction treatment settings.

Keywords: Cervical cancer screening; disparities; substance use-related diagnosis; women.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportions of ‘positive cervical cancer screening’ by type of result in women with and without a substance use-related diagnosis. Women can be included in two categories if they have both abnormal pathology in addition to being high risk HPV DNA positive. Solid lines represent binomial 95% confidence intervals
See this image and copyright information in PMC

References

    1. Collaborators GAaDU. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. December 2018;5(12):987–1012. doi:10.1016/S2215-0366(18)30337-7 - DOI - PMC - PubMed
    1. Quality. CfBHSa. Results from the 2019 National Survey on Drug Use and Health: Detailed tables. 2020. Accessed October 29, 2020. https://www.samhsa.gov/data/
    1. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. Apr 2006;3(2):A42. - PMC - PubMed
    1. Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. May 2019;198:80–86. doi:10.1016/j.drugalcdep.2019.01.037 - DOI - PMC - PubMed
    1. van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. Jul 2013;131(1–2):23–35. doi:10.1016/j.drugalcdep.2013.02.018 - DOI - PubMed

Publication types